Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.210
+0.090 (4.25%)
Nov 21, 2024, 4:00 PM EST - Market closed
Minerva Neurosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 15 | 43 | 8 | 34 | 100 | 277 | |
| Market Cap Growth | -61.30% | 406.54% | -75.19% | -65.73% | -64.01% | 5.91% | |
| Enterprise Value | 48 | 76 | 40 | 33 | 67 | 218 | |
| Last Close Price | 2.12 | 6.15 | 1.59 | 6.41 | 18.72 | 56.88 | |
| PE Ratio | - | - | - | - | 51.45 | - | |
| PS Ratio | - | - | - | - | 2.43 | - | |
| PB Ratio | -0.86 | -1.51 | -0.42 | 4.29 | 1.90 | 9.99 | |
| P/TBV Ratio | - | - | - | - | 2.64 | 21.49 | |
| EV/Sales Ratio | - | - | - | - | 1.64 | - | |
| EV/EBITDA Ratio | - | - | - | - | 36.24 | - | |
| EV/EBIT Ratio | - | - | - | - | 36.55 | - | |
| Debt / Equity Ratio | -2.77 | -2.88 | -3.68 | 8.32 | 0.00 | 0.01 | |
| Debt / EBITDA Ratio | - | - | - | - | 0.05 | - | |
| Asset Turnover | - | - | - | - | 0.61 | - | |
| Quick Ratio | 5.92 | 12.25 | 28.46 | 21.55 | 8.02 | 6.92 | |
| Current Ratio | 6.23 | 12.57 | 29.15 | 22.07 | 8.68 | 7.11 | |
| Return on Equity (ROE) | - | - | - | -164.60% | 4.83% | -122.30% | |
| Return on Assets (ROA) | -28.91% | -25.81% | -23.86% | -27.98% | 1.71% | -32.81% | |
| Return on Capital (ROIC) | -31.21% | -26.94% | -24.64% | -29.67% | 2.86% | -60.07% | |
| Earnings Yield | -21.43% | -69.76% | -378.15% | -145.84% | 1.94% | -26.01% | |
| FCF Yield | -131.84% | -34.38% | -290.45% | -71.89% | -33.87% | -15.65% | |
| Buyback Yield / Dilution | -27.34% | -21.84% | 0.00% | -4.41% | -4.88% | -0.57% | |
| Total Shareholder Return | -27.34% | -21.84% | 0.00% | -4.41% | -4.88% | -0.57% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.